Insulet (PODD) Cash from Operations (2010 - 2026)
Insulet's (PODD) quarterly Cash from Operations came in at $88.4 million in Q2 2026, down 55.01% on a YoY basis from $196.5 million in Q2 2025, and down 22.32% quarter-over-quarter from $113.8 million in Q1 2026.
Analysis
Insulet (PODD) Cash from Operations (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Cash from Operations for 17 consecutive years, with $88.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Operations fell 55.01% year-over-year to $88.4 million; the trailing twelve-month figure through Jun 2026 stood at $511.2 million (down 0.95% YoY), and the FY2025 full-year result was $569.3 million, up 32.33% from the prior year.
- Cash from Operations fell to $88.4 million in Q2 2026 per PODD's latest filing, from $113.8 million in the prior quarter.
- Across five years, Cash from Operations topped out at $196.5 million in Q2 2025 and bottomed at -$13.7 million in Q1 2022.
- Historically, Cash from Operations has averaged $81.5 million across 5 years, with a median of $75.3 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Cash from Operations jumped 17420.0% in 2024, then plunged 55.01% in 2026.
- Over 5 years, Cash from Operations stood at $50.7 million in 2022, then fell by 10.85% to $45.2 million in 2023, then surged by 226.33% to $147.5 million in 2024, then climbed by 24.27% to $183.3 million in 2025, then plunged by 51.77% to $88.4 million in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered $88.4 million, $113.8 million, and $183.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | 88.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.40 Mn |
| Mar 31, 2026 | 113.80 Mn |
| Dec 31, 2025 | 183.30 Mn |
| Sep 30, 2025 | 125.70 Mn |
| Jun 30, 2025 | 196.50 Mn |
| Mar 31, 2025 | 63.80 Mn |
| Dec 31, 2024 | 147.50 Mn |
| Sep 30, 2024 | 108.30 Mn |
| Jun 30, 2024 | 86.80 Mn |
| Mar 31, 2024 | 87.60 Mn |
| Dec 31, 2023 | 45.20 Mn |
| Sep 30, 2023 | 56.00 Mn |
| Jun 30, 2023 | 44.00 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 50.70 Mn |
| Sep 30, 2022 | 56.70 Mn |
| Jun 30, 2022 | 25.30 Mn |
| Mar 31, 2022 | -13.70 Mn |
| Dec 31, 2021 | -25.50 Mn |
| Sep 30, 2021 | -25.80 Mn |